Wire · opportunities
Clinical data harmonization is the bottleneck for life sciences AI
◆ Sectors
◆ Source
◆ Verified
Fusion42 · 26 September 2026 · Fusion42 review
Life sciences companies face significant delays in scaling AI applications due to challenges in clinical data harmonization, which requires restructured data ingestion, mapping, and governance. Mid-market firms and biotech specialists face greater scaling challenges compared to large pharmaceutical companies, with AI value concentrated in use cases where clean, verifiable data integrates into daily workflows.
This Wire brief sits within Fusion42's coverage of Biotech, AI Infrastructure and Data & Analytics.
◆ ◆ The Wire takeaway
You must prioritise clinical data management and rearchitect your AI pipelines this week to move past proof-of-concept delays into deployment. Struggling SMEs face the clearest opening to lead in AI by solving the data plumbing that big pharma accepts as granted.
◆ Coverage
1 source · 26 Sep 2026
◆ Related on Wire
◆ Topics